Total
0
Shares
Althea Group (ASX:AGH) - CEO, Joshua Fegan
CEO, Joshua Fegan
Source: Althea
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Althea Group’s (AGH) subsidiary, Peak Processing Solutions, has received a purchase order from Cronos Group’s subsidiary, Peace Naturals Project
  • The order is valued at C$134,000 (roughly A$137,216) and will see Peak extract cannabinoids using the hydrocarbon extraction method to process these into cannabis concentrate products
  • Significantly, Peak is one of the few processors in Canada capable of producing hydrocarbon extracted cannabis concentrates
  • This puts Althea’s subsidiary at the forefront of servicing an in-demand product type
  • Production is expected to begin this month and products will be sold into the Canadian cannabis market
  • Althea’s shares are up a slight 0.98 per cent and are trading at 51.5 cents

Althea Group’s (AGH) subsidiary, Peak Processing Solutions, has received an C$134,000 (roughly A$137,216) purchase order from Peace Naturals Project.

Peace Naturals is a subsidiary of Canada-based cannabis company, Cronos Group.

The one-year commercial services agreement will see Peak execute the hydrocarbon extraction of cannabis biomass and process the extract into cannabis concentrate products. Once they’re ready, they’ll be sold in the Canadian cannabis market.

Hydrocarbon extraction is a method used to extract cannabinoids from cannabis plant material. Hydrocarbons, such as propane and butane, essentially act as solvents that can strip cannabinoids from plant material. 

Peak specialises in manufacturing cannabis-infused drinks, concentrates and topical products at its facility in Ontario. The facility is one of the first large-scale, independent processing facilities of its kind.

The subsidiary is also one of the few processors in Canada that is capable of producing hydrocarbon extracted cannabis concentrates. This puts Peak at the forefront of servicing this in-demand product type.

“It is pleasing to see how quickly the Peak business is taking off this year, attracting a world-class supply agreement with Peace Naturals, just a few months post licensing,” Althea CEO Joshua Fegan said.

In September last year, Health Canada granted Peak a Standard Processing Licence which allowed it to start manufacturing and selling cannabis products.

“We look forward to continuing to secure supply agreements with other like-minded players in the fast-growing Cannabis 2.0 space and further demonstrating the world-class cannabis extraction capabilities of Peak,” Joshua concluded.

Production is expected to begin this month.

Althea’s shares are up a slight 0.98 per cent and are trading at 51.5 cents at 1:04 pm AEDT.

AGH by the numbers
More From The Market Herald
Advanced Human Imaging, AHI- CEO and Co-Founder Vlado Bosanac

" Advanced Human Imaging (ASX:AHI) appoints Edward F. Greissing Jr. to board

Advanced Human Imaging (AHI) has appointed Edward F. Greissing Jr. to board effective from November 30, 2021.
Rhythm Biosciences (ASX:RHY) - CEO, Glenn Gilbert

" Rhythm Biosciences (ASX:RHY) achieves CE Mark for ColoSTAT

Cancer diagnostic technology company Rhythm Biosciences (RHY) has achieved CE Mark certification for ColoSTAT.
EMVision Medical Devices (ASX:EMV) - CEO, Ron Weinberger

" EMVision Medical Devices (ASX:EMV) reports more strong results

Medical device maker EMVision (EMV) is spiking on the ASX today after releasing further results from a pilot clinical trial of its brain
ECS Botanics (ASX:ECS) - Managing Director and Founder, Alex Keach

" ECS Botanics’ (ASX:ECS) subsidiary buds $4.9m supply agreement

ECS Botanics’ (ECS) subsidiary has secured a $4.9 million agreement to supply resin to Australian cannabis company, Cannvalate.